This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Jim Cramer's Top Takeaways: Allergan, Royal Caribbean, Whole Foods Market

Cramer says Allergan is the drug company of the future and he wants to go cruising with Royal Caribbean.

Business Borrowers Optimistic, Still Working to Reduce Risks

Mid-sized businesses are optimistic about the economy heading into 2016, says Tony Bedikian, managing director of Global Markets at Citizens Bank.

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Cramer will be watching for earnings from Apple, General Dynamics and Starbucks.

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.

Jim Cramer's 'Mad Money' Recap: What Ails the Market? Drug Stocks

The drug stocks are competing with the oil patch for the prize of the worst sector in the entire market, Cramer says.

Jim Cramer's 'Mad Money' Recap: Here's Where the Bear Tide Is Turning

When the facts change, investors need to change their minds, Cramer says.

Jim Cramer's Top Takeaways: ConAgra, Nike, Apple, Starbucks, Wells Fargo

Cramer says ConAgra is attractive at current levels, don't buy Wells Fargo all at once, and Nike, Apple and Starbucks show the Chinese consumer is alive and buying.

Jim Cramer's Top Takeaways: Apple, Brunswick, Halyard Health

Cramer says Apple is not for the squeamish thanks to China, Brunswick is more than just boats.

Jim Cramer's Top Takeaways: Apple, Diageo, Imax, Blue Buffalo, Freshpet, Brixmor

Cramer says Apple and Diageo are being tarnished by China while he wouldn't invest in Blue Buffalo or Freshpet unless they merged.

Jim Cramer's Top Takeaways: Sonic, Darden, Fitbit, Johnson Controls

Cramer says Fitbit is a real company with real earnings and a bargain despite the big rally in the stock.

Page 1 of 6
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs